Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) Net-Net Working Capital: RM0.93 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKLS:7178 Y.S.P. Southeast Asia Holding Bhd XKLS:7178
73 GF Score
Price RM2.01
GF Value RM2.32
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Y.S.P. Southeast Asia Holding Bhd Net-Net Working Capital?

Y.S.P. Southeast Asia Holding Bhd XKLS:7178 -0.50% 73 Net-Net Working Capital is RM0.93 as of Jun. 2026. GuruFocus rates XKLS:7178 with a GF Score™ of 73/100 and a GF Value™ of RM2.32 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 403 Drug Manufacturers companies, Y.S.P. Southeast Asia Holding Bhd ranks better than 87.59% on this metric.

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.

Y.S.P. Southeast Asia Holding Bhd's Net-Net Working Capital for the quarter that ended in Jun. 2026 was RM0.93.

The industry rank for Y.S.P. Southeast Asia Holding Bhd's Net-Net Working Capital or its related term are showing as below:

XKLS:7178's Price-to-Net-Net-Working-Capital is ranked better than
87.59% of 403 companies
in the Drug Manufacturers industry
Industry Median: 7.85 vs XKLS:7178: 2.16

Y.S.P. Southeast Asia Holding Bhd  (XKLS:7178) Net-Net Working Capital Explanation

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.


Y.S.P. Southeast Asia Holding Bhd Net-Net Working Capital Related Terms


Y.S.P. Southeast Asia Holding Bhd Net-Net Working Capital Historical Data

* Premium members only.

The historical data trend for Y.S.P. Southeast Asia Holding Bhd's Net-Net Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Y.S.P. Southeast Asia Holding Bhd Net-Net Working Capital Chart

Y.S.P. Southeast Asia Holding Bhd Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net-Net Working Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.82 0.95 0.85 0.93 0.95

Y.S.P. Southeast Asia Holding Bhd Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Net-Net Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.87 0.93 0.95 0.98 0.93

XKLS:7178 vs ZTS, UTHR, VTRS: Net-Net Working Capital Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Y.S.P. Southeast Asia Holding Bhd's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Y.S.P. Southeast Asia Holding Bhd Price-to-Net-Net-Working-Capital vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Y.S.P. Southeast Asia Holding Bhd's Price-to-Net-Net-Working-Capital distribution charts can be found below:

* The bar in red indicates where Y.S.P. Southeast Asia Holding Bhd's Price-to-Net-Net-Working-Capital falls into.


XKLS:7178
73GF Score
Y.S.P. Southeast Asia Holding Bhd XKLS:7178
Net-Net Working Capital is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Y.S.P. Southeast Asia Holding Bhd Net-Net Working Capital Calculation

Y.S.P. Southeast Asia Holding Bhd's Net-Net Working Capital (NNWC) per share for the fiscal year that ended in Dec. 2025 is calculated as

Net-Net Working Capital(A: Dec. 2025 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(148.099+0.75 * 65.519+0.5 * 120.761-115.36
-0-7.824)/141.845
=0.95

Y.S.P. Southeast Asia Holding Bhd's Net-Net Working Capital (NNWC) per share for the quarter that ended in Jun. 2026 is calculated as

Net-Net Working Capital(Q: Jun. 2026 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(160.908+0.75 * 68.11+0.5 * 119.58-131.667
-0-8.155)/141.845
=0.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.

In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

This is a conservative way of estimating the company's value.

What does a Net-Net Working Capital of RM0.93 mean?
Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) has a Net-Net Working Capital of RM0.93 as of Jun. 2026. Ben Graham defined net-net working capital as the per-share sum of cash, 75% of receivables and 50% of inventory less total liabilities. View historical data on Y.S.P. Southeast Asia Holding Bhd According to the industry distribution chart, Y.S.P. Southeast Asia Holding Bhd ranks #50 out of 403 companies in the Drug Manufacturers industry, placing it in the top 12.4%.
Is Y.S.P. Southeast Asia Holding Bhd's Net-Net Working Capital too high?
Y.S.P. Southeast Asia Holding Bhd's current Net-Net Working Capital is RM0.93. Based on the distribution chart, Y.S.P. Southeast Asia Holding Bhd ranks #50 out of 403 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Y.S.P. Southeast Asia Holding Bhd has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Y.S.P. Southeast Asia Holding Bhd's Net-Net Working Capital compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Y.S.P. Southeast Asia Holding Bhd ranks #50 out of 403 companies for Net-Net Working Capital. This places Y.S.P. Southeast Asia Holding Bhd in the top 12% of its industry — outperforming the majority of peers. The industry median Net-Net Working Capital is 7.85. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net-Net Working Capital for a Drug Manufacturers company?
The median Net-Net Working Capital among Drug Manufacturers companies is 7.85, based on 403 companies in the industry. Companies in the top quartile (top 25%) have a Net-Net Working Capital significantly above this median, while those in the bottom quartile fall well below. However, Net-Net Working Capital should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net-Net Working Capital mean?
A high Net-Net Working Capital can signal that a stock is expensive relative to its fundamentals. Ben Graham defined net-net working capital as the per-share sum of cash, 75% of receivables and 50% of inventory less total liabilities. View historical data on Y.S.P. Southeast Asia Holding Bhd For the Drug Manufacturers industry, the median Net-Net Working Capital is 7.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Y.S.P. Southeast Asia Holding Bhd's current Net-Net Working Capital is RM0.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Y.S.P. Southeast Asia Holding Bhd stock overvalued right now?
Based on GuruFocus' analysis, Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) is currently considered Modestly Undervalued. The stock's GF Value™ is RM2.32, compared to a current price of RM2.01 — trading 13.4% below its estimated fair value. The current Net-Net Working Capital is RM0.93. Y.S.P. Southeast Asia Holding Bhd's overall GF Score™ is 73/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net-Net Working Capital calculated?
Net-Net Working Capital is calculated from a company's financial statements. For Y.S.P. Southeast Asia Holding Bhd (XKLS:7178), the current Net-Net Working Capital is RM0.93 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) Overvalued in 2026?

Based on GuruFocus' analysis, Y.S.P. Southeast Asia Holding Bhd stock appears to be undervalued. The current stock price of RM2.01 is trading 13.4% below its estimated GF Value™ of RM2.32. GuruFocus considers Y.S.P. Southeast Asia Holding Bhd to be Modestly Undervalued.

Key valuation signals for XKLS:7178:

  • Net-Net Working Capital: RM0.93
  • GF Value™: RM2.32 vs. price of RM2.01 (13.4% below fair value)
  • GF Score™: 73/100 with 2 warning signs

No single metric tells the full story. See the XKLS:7178 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Y.S.P. Southeast Asia Holding Bhd Business Description

Address Number 1, Jalan Wan Kadir, Level 22, Menara LGB, Taman Tun Dr. Ismail, Kuala Lumpur, MYS, 60000
Y.S.P. Southeast Asia Holding Bhd is an investment company, that engages in the pharmaceutical business, and provision of management services. The company operates through the following segments: Trading, Manufacturing, and Investment Holding. The Trading segment imports, exports, and trading in various kinds of pharmaceutical products, and traditional herbal and veterinary products. The Manufacturing segment manufactures pharmaceutical products. The Investment Holding segment focuses on investment holding activity. The firm's majority of revenue comes from the Manufacturing segment. The majority of revenue is derived from Malaysia.
73GF Score

Get the complete analysis for XKLS:7178

Net-Net Working Capital is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM2.01
Price
RM2.32
GF Value